Aclaris Therapeutics, Inc. (ACRS): Weighted Average Diluted Shares
122.56M
Year ended 2025-12-31
+23.4%
3-year compound annual growth
+23.6%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 122.56M | +58.6% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 77.30M | +10.7% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 69.81M | +7.0% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | 65.21M | +15.0% | 2024-02-27, From 2022-01-01 |
| 2021-12-31 | 56.73M | +33.4% | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | 42.54M | +2.9% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | 41.32M | n/a | 2022-02-24, From 2019-01-01 |